AS PRFoods financials
AS PRFoods
529900PFXFO2ZDCRNK93 | Line item | 2023 | 2022 |
|---|---|---|
| Income statement | ||
| Revenue | €19.6M | €42.1M |
| Cost of sales | €16.0M | €39.0M |
| Gross profit | €3.6M | €3.1M |
| Distribution costs | €2.7M | €4.8M |
| Administrative expenses | €2.0M | €2.4M |
| Operating profit (EBIT) | -€970.0K | -€4.2M |
| Finance costs | €1.2M | €1.7M |
| Profit before tax | €396.0K | -€8.2M |
| Income tax expense | €65.0K | -€63.0K |
| Profit for the year | €331.0K | -€8.2M |
| — attributable to owners | €303.0K | -€8.1M |
| — attributable to NCI | €28.0K | -€17.0K |
| Total comprehensive income | €101.0K | -€7.9M |
| Per share | ||
| Basic EPS | €0.01 | €-0.21 |
| Diluted EPS | €0.01 | €-0.17 |
| Free cash flow / share | €-0.02 | €0.01 |
| Cash flow statement | ||
| Net cash from operating activities | -€468.0K | €929.0K |
| Net cash from investing activities | €6.9M | -€2.9M |
| Net cash from financing activities | -€5.9M | -€331.0K |
| Proceeds from borrowings | €2.1M | €2.8M |
| Repayments of borrowings | €1.3M | €325.0K |
| Lease liability payments | €945.0K | €663.0K |
| Balance sheet | ||
| Total assets | €30.2M | €38.9M |
| Non-current assets | €25.1M | €31.0M |
| Property, plant & equipment | €6.6M | €8.9M |
| Intangible assets & goodwill | €18.2M | €21.8M |
| Current assets | €5.1M | €7.9M |
| Inventories | €1.9M | €2.2M |
| Trade & other receivables | €1.8M | €2.2M |
| Cash & equivalents | €394.0K | €110.0K |
| Total equity | €8.3M | €8.1M |
| — attributable to owners | €8.0M | €7.9M |
| Non-controlling interests | €260.0K | €199.0K |
| Non-current liabilities | €16.8M | €19.8M |
| Long-term borrowings | €15.0M | €17.7M |
| Current liabilities | €5.1M | €11.1M |
| Trade & other payables | €3.0M | €4.0M |
| Deferred tax liabilities | €1.5M | €1.6M |
| Derived metrics | ||
| Free cash flow | -€716.0K | €247.0K |
| Operating margin | -5.0% | -9.9% |
| Net margin | 1.7% | -19.4% |
| Return on equity | 4.0% | -101.3% |
| Cash conversion ratio | -1.41× | -0.11× |
| Capex coverage | -1.89× | 1.36× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | -€7.0K | €1.5M |
| Adjustments For Decrease Increase In Trade Account Receivable | -€403.0K | -€1.1M |
| Adjustments For Depreciation and Amortisation Expense | €1.3M | €2.1M |
| Adjustments For Fair Value Gains Losses | -€1.1M | €1.8M |
| Adjustments For Gain Loss On Disposals Property Plant and Equipment | €2.4M | €13.0K |
| Adjustments For Increase Decrease In Trade Account Payable | €189.0K | €1.2M |
| Cash Flows From Used In Increase Decrease In Current Borrowings | -€4.5M | -€930.0K |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | -€7.0M | €2.2M |
| Cash Receipts From Repayment of Advances and Loans Made To Other Parties Classified As Investing Activities | €0 | €5.0K |
| Comprehensive Income Attributable To Noncontrolling Interests | €28.0K | -€17.0K |
| Comprehensive Income Attributable To Owners of Parent | €73.0K | -€7.9M |
| Current Biological Assets | €772.0K | €3.0M |
| Current Borrowings and Current Portion of Noncurrent Borrowings | €2.1M | €7.1M |
| Deferred Tax Assets | €0 | €93.0K |
| Equity and Liabilities | €30.2M | €38.9M |
| Gains Losses On Fair Value Adjustment Biological Assets | €0 | -€420.0K |
| Income Taxes Paid Refund Classified As Operating Activities | €0 | €147.0K |
| Increase Decrease Through Transfers and Other Changes Equity | €140.0K | €160.0K |
| Interest Paid Classified As Financing Activities | €1.2M | €1.2M |
| Interest Received Classified As Investing Activities | €1.0K | €14.0K |
| Issued Capital | €7.7M | €7.7M |
| Liabilities | €22.0M | €30.9M |
| Noncurrent Government Grants | €317.0K | €265.0K |
| Operating Expense Excluding Cost of Sales | €4.7M | €7.2M |
| Other Adjustments For Noncash Items | €1.6M | €3.8M |
| Other Comprehensive Income | -€230.0K | €280.0K |
| Other Inflows Outflows of Cash Classified As Investing Activities | €0 | -€30.0K |
| Other Noncurrent Financial Assets | €381.0K | €229.0K |
| Other Noncurrent Liabilities | €0 | €204.0K |
| Other Operating Income Expense | €150.0K | €307.0K |
| Prepayments | €304.0K | €413.0K |
| Proceeds From Disposals of Property Plant and Equipment Intangible Assets Other Than Goodwill Investment Property and Other Noncurrent Assets | €66.0K | €13.0K |
| Proceeds From Government Grants Classified As Investing Activities | €67.0K | €58.0K |
| Purchase of Property Plant and Equipment Intangible Assets Other Than Goodwill Investment Property and Other Noncurrent Assets | €248.0K | €682.0K |
| Reclassification Adjustments On Exchange Differences On Translation Net of Tax | €231.0K | -€280.0K |
| Reserve of Change In Value of Foreign Currency Basis Spreads | €609.0K | €839.0K |
| Retained Earnings | -€14.0M | -€14.4M |
| Share of Profit Loss of Associates Accounted For Using Equity Method | €153.0K | €0 |
| Share Premium | €14.0M | €14.0M |
| Statutory Reserve | €51.0K | €51.0K |
| Treasury Shares | €390.0K | €390.0K |
Every line item above is a fact tagged in AS PRFoods's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.